BioPS® (Soy Phosphatidylserine — ECA Healthcare)

Evidence Level
Moderate
0 Clinical Trials
3 Documented Benefits
3/5 Evidence Score

BioPS® is a soy-derived phosphatidylserine (PS) from ECA Healthcare, a phospholipid that is a key building block of brain-cell membranes. We found no published trial of BioPS itself: a registered memory trial of BioPS in 114 Japanese adults was completed in 2024 (NCT05962008), but we found no BioPS results from it. PS products may use an FDA qualified health claim about cognitive dysfunction in older adults only with FDA's disclaimer that there is little scientific evidence supporting it, and the studies FDA counted used cow brain PS, not soy PS like BioPS. In 2016 ECA Healthcare asked FDA to stop evaluating its US GRAS notices for soy, sunflower and fish PS.

Studied Dose No BioPS dose has been tested in a published trial that we found; PS memory trials mostly used 300 mg/day.
Active Compound Phosphatidylserine (PS), a phospholipid, derived from non-GMO soy lecithin.

Benefits

Memory: no published BioPS trial

No BioPS trial result has been published that we found. Trials of other soy PS products in older adults with memory complaints were mixed: the largest university-run one found no benefit, and others found gains only in subgroups.

Brain-cell membrane support

As a major phospholipid in brain-cell membranes, PS supports the structure and signaling of neurons.

Stress and focus: no BioPS trial

Small trials of other PS products have looked at stress hormones, with mixed results; no BioPS trial has reported on stress or focus.

Mechanism of action

1

Membrane phospholipid

Phosphatidylserine is a core component of neuronal membranes, supporting fluidity, receptor function, and cell-to-cell signaling.

2

Neurotransmission support

PS has been proposed to support neurotransmitter release, mainly from animal studies; no BioPS study measured this.

Clinical trials

Side effects and drug interactions

Common Potential side effects

We found no published BioPS trial reporting side effects.
Side effects were uncommon in PS trials; a few people reported stomach upset.
Contains soy; avoid if you have a soy allergy.

Important Drug interactions

Blood thinners and antiplatelet drugs: we found no interaction study; tell your prescriber if combining.
Acetylcholinesterase inhibitors (donepezil, rivastigmine, galantamine): a theoretical added effect on acetylcholine, not studied. Tell your prescriber.
Tell your doctor about all supplements if you take medication.

Frequently asked questions about BioPS® (Soy Phosphatidylserine — ECA Healthcare)

What is BioPS?

BioPS® is a soy-derived phosphatidylserine (PS) from ECA Healthcare, a phospholipid that is a key building block of brain-cell membranes. We found no published trial of BioPS itself: a registered memory trial of BioPS in 114 Japanese adults was completed in 2024 (NCT05962008), but we found no BioPS results from it.

What is BioPS used for?

BioPS is researched primarily for Cognitive. No BioPS trial result has been published that we found. Trials of other soy PS products in older adults with memory complaints were mixed: the largest university-run one found no benefit, and others found gains only in subgroups.

What is the recommended dosage of BioPS?

No BioPS dose has been tested in a published trial that we found; PS memory trials mostly used 300 mg/day. Always follow the product label and check with a healthcare provider for personal advice.

Is BioPS safe, and does it have side effects?

Side effects and cautions reported for BioPS include: We found no published BioPS trial reporting side effects. Side effects were uncommon in PS trials; a few people reported stomach upset. It may also interact with some medications. BioPS is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does BioPS interact with any medications?

Possible interactions include: Blood thinners and antiplatelet drugs: we found no interaction study; tell your prescriber if combining. Acetylcholinesterase inhibitors (donepezil, rivastigmine, galantamine): a theoretical added effect on acetylcholine, not studied. Tell your prescriber. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for BioPS?

NutraSmarts rates the evidence for BioPS as Moderate (3 out of 5). It is backed by 3 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(3 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Cenacchi T, Bertoldin T, Farina C, et al. Cognitive decline in the elderly: a double-blind, placebo-controlled multicenter study on efficacy of phosphatidylserine administration Aging (Milano). 1993;5(2):123-33. doi: 10.1007/BF03324139.PubMedUsed to support: Multicenter double-blind RCT (300 mg/day BC-PS vs placebo, 6 months, elderly patients with moderate to severe cognitive decline across 23 Italian centers) showing significant improvements in behavioral and cognitive parameters. This trial used bovine-cortex PS (BC-PS), not soy-PS; it is PS compound-level evidence from a different source than BioPS — not a soy-PS or BioPS-branded trial.
  2. Moré MI, Freitas U, Rutenberg D Positive effects of soy lecithin-derived phosphatidylserine plus phosphatidic acid on memory, cognition, daily functioning, and mood in elderly patients with Alzheimer's disease and dementia Advances in Therapy. 2014;31(12):1247-62. doi: 10.1007/s12325-014-0165-1.PubMedUsed to support: Study of soy lecithin-derived phosphatidylserine plus phosphatidic acid (a PS+PA combination, not PS alone) reporting improvements in memory, mood, and daily functioning in elderly patients with Alzheimer’s disease and dementia. This is combination compound-level evidence in a disease population; results cannot be attributed to soy-PS alone or to BioPS specifically.
  3. Starks MA, Starks SL, Kingsley M, et al. The effects of phosphatidylserine on endocrine response to moderate intensity exercise Journal of the International Society of Sports Nutrition. 2008;5:11. doi: 10.1186/1550-2783-5-11.PubMedUsed to support: Double blind crossover trial in 10 healthy young men: 600 mg a day of soy PS for 10 days lowered peak cortisol (about 39%) after moderate-intensity cycling; ACTH was not measured. Funded by Increnovo, with publication paid by Chemi Nutra. Not a BioPS trial.